Worth Venture Partners’s Surmodics SRDX Stock Holding History

Worth Venture Partners’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-23,300	Closed	-$106K	–	112
2019 Q2	$106K	Buy	+23,300	New	+$984K	0.06%	73

Other funds holding SRDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Worth Venture Partners's SRDX Position: Q3 2019 in Review

Worth Venture Partners sold out of Surmodics (SRDX) in Q3 2019, closing a stake of 34 shares — an estimated $1K sold.

Worth Venture Partners first reported a position in SRDX in Q2 2019 and held it in 1 quarter. The position peaked at $1K in Q2 2019. 146 funds tracked by Wall St. Rank hold SRDX as of Q3 2019.

Worth Venture Partners reported no remaining Surmodics position as of Q3 2019 after selling out during the quarter.
Worth Venture Partners sold 34 Surmodics shares in Q3 2019, an estimated $1K.
Worth Venture Partners first reported a position in Surmodics in Q2 2019 and held it in 1 quarter.
Worth Venture Partners's Surmodics position peaked at $1K in Q2 2019.
146 funds tracked by Wall St. Rank held Surmodics as of Q3 2019.

Based on Worth Venture Partners's 13F filing for Q3 2019, filed 12 Nov 2019.